SELEXID TAB 185MG DIN 00657212
Status: Cancelled Post Market
Holder: LEO PHARMA INC
Health Canada record
| Active ingredient(s) | PIVMECILLINAM (PIVMECILLINAM HYDROCHLORIDE) 185 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | J01CA08 PIVMECILLINAM |
| Original market date | 31-Dec-1985 |
| Current status date | 02-Aug-2012 |
| Source | Health Canada DPD |
Establishment licence of the holder
LEO Pharma Inc — licence 100195, currently licensed, last inspection rating C (2026-05-27).
No Canadian shortage report is currently matched to this DIN.
Request a quote for SELEXID TAB 185MG